Back
Achilles Therapeutics PLC 10K Form
Sell
43
ACHL
Achilles Therapeutics PLC
Last Price:
1.06
Seasonality Move:
-11.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ACHL News And Ratings
See the #1 stock for the next 7 days that we like better than ACHL
ACHL Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.51 |
| Price / Book: | 0.42 |
Profitability
| EPS (TTM): | -1.65000 |
|---|---|
| Net Income (TTM): | $-66.88M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Achilles Therapeutics PLC Earnings Forecast
Key Achilles Therapeutics PLC Financial Ratios
- Per Share Earnings over the last 5 years have been positive in 3 years.
Achilles Therapeutics PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ACHL |
| Website: | achillestx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ACHL Technical Analysis vs Fundamental Analysis
Sell
43
Achilles Therapeutics PLC (ACHL)
is a Sell
Is Achilles Therapeutics PLC a Buy or a Sell?
-
Achilles Therapeutics PLC stock is rated a Sell
The current Achilles Therapeutics PLC [ACHL] share price is $1.06. The Score for ACHL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.